vimarsana.com

Page 242 - எங்களுக்கு தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

US trial of COVID-19 blood plasma halted after no benefit found

The U.S trial had enrolled 511 of 900 participants, who were either given blood plasma from recovered COVID-19 patients or a placebo.

Coronavirus: Latest on COVID-19 from around the world - Wednesday, March 3

Gwyneth Paltrow s False Remedies Will Not Protect You From Long COVID

Gwyneth Paltrow s False Remedies Will Not Protect You From Long COVID Tanner Garrity, provided by FacebookTwitterEmail Last week, the U.S. National Institutes of Health (NIH) launched a new initiative to study a phenomenon known unofficially as “long COVID.” You likely know of someone grappling with it. It refers to those still struggling with symptoms of COVID-19 especially brain fog, fatigue or shortness of breath in the weeks or even months following their initial bout with the illness. Even if we manage to end the pandemic this year, the reach of long COVID could affect millions of people worldwide for years to come. There is so much we don’t yet know about this disease hence the $1.15 billion Congress has allocated over the next four years to support “research into the prolonged health consequences” of SARS-CoV-2.

Updates on CCP Virus: Recent Case Drops Could Change Due to New Variants

Updates on CCP Virus: Recent Case Drops Could Change Due to New Variants
theepochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theepochtimes.com Daily Mail and Mail on Sunday newspapers.

Arrêt d essais aux États-Unis sur un traitement au plasma de patients guéris

Arrêt d essais aux États-Unis sur un traitement au plasma de patients guéris
journaldequebec.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from journaldequebec.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.